Literature DB >> 29149938

Novel Interventions: What's New and the Future.

Jean-Louis Vincent1, David Grimaldi2.   

Abstract

Despite decades of sepsis research, no specific therapies for sepsis have emerged and current management still relies on source control, antibiotics, and organ support. With improved understanding of sepsis pathophysiology and the development of new techniques to enable better characterization of patients with sepsis, clinical trials are beginning to better target new interventions at those patients most likely to respond. This article discusses advances in sepsis therapeutics designed to improve endothelial cell function, purify the blood to help restore immune homeostasis, and provide immunostimulation for patients with immune exhaustion.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Immunosuppression; Interferon; Microcirculation; Organ dysfunction; Personalization; Septic shock; Thrombomodulin

Mesh:

Substances:

Year:  2017        PMID: 29149938     DOI: 10.1016/j.ccc.2017.08.012

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  6 in total

1.  Pulsed Ultrasound of the Spleen Prolongs Survival of Rats With Severe Intra-abdominal Sepsis.

Authors:  Aimee Zhang; Eric J Charles; Jinyan Xing; Robert G Sawyer; Zequan Yang
Journal:  J Surg Res       Date:  2020-12-03       Impact factor: 2.192

2.  Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab.

Authors:  Richard S Hotchkiss; Elizabeth Colston; Sachin Yende; Elliott D Crouser; Greg S Martin; Timothy Albertson; Raquel R Bartz; Scott C Brakenridge; Matthew J Delano; Pauline K Park; Michael W Donnino; Mark Tidswell; Florian B Mayr; Derek C Angus; Craig M Coopersmith; Lyle L Moldawer; Ian M Catlett; Ihab G Girgis; June Ye; Dennis M Grasela
Journal:  Intensive Care Med       Date:  2019-10-01       Impact factor: 17.440

3.  Apoptotic cell therapy for cytokine storm associated with acute severe sepsis.

Authors:  Netanel Karbian; Avraham Abutbul; Raja El-Amore; Ran Eliaz; Ronen Beeri; Barak Reicher; Dror Mevorach
Journal:  Cell Death Dis       Date:  2020-07-15       Impact factor: 8.469

4.  Identification of a transcriptome profile associated with improvement of organ function in septic shock patients after early supportive therapy.

Authors:  Matteo Barcella; Bernardo Bollen Pinto; Daniele Braga; Francesca D'Avila; Federico Tagliaferri; Marie-Angelique Cazalis; Guillaume Monneret; Antoine Herpain; Karim Bendjelid; Cristina Barlassina
Journal:  Crit Care       Date:  2018-11-21       Impact factor: 9.097

5.  Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis- A Phase Ib Clinical Trial.

Authors:  Peter Vernon van Heerden; Avraham Abutbul; Sigal Sviri; Eitan Zlotnick; Ahmad Nama; Sebastian Zimro; Raja El-Amore; Yehudit Shabat; Barak Reicher; Batla Falah; Dror Mevorach
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

6.  Getting the invite list right: a discussion of sepsis severity scoring systems in severe complicated intra-abdominal sepsis and randomized trial inclusion criteria.

Authors:  Matti Tolonen; Federico Coccolini; Luca Ansaloni; Massimo Sartelli; Derek J Roberts; Jessica L McKee; Ari Leppaniemi; Christopher J Doig; Fausto Catena; Timothy Fabian; Craig N Jenne; Osvaldo Chiara; Paul Kubes; Yoram Kluger; Gustavo P Fraga; Bruno M Pereira; Jose J Diaz; Michael Sugrue; Ernest E Moore; Jianan Ren; Chad G Ball; Raul Coimbra; Elijah Dixon; Walter Biffl; Anthony MacLean; Paul B McBeth; Juan G Posadas-Calleja; Salomone Di Saverio; Jimmy Xiao; Andrew W Kirkpatrick
Journal:  World J Emerg Surg       Date:  2018-04-06       Impact factor: 5.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.